Editorial for "Multi-site concordance of diffusion weighted imaging quantification for assessing prostate cancer aggressiveness"
- PMID: 34767691
- DOI: 10.1002/jmri.27994
Editorial for "Multi-site concordance of diffusion weighted imaging quantification for assessing prostate cancer aggressiveness"
Comment on
-
Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness.J Magn Reson Imaging. 2022 Jun;55(6):1745-1758. doi: 10.1002/jmri.27983. Epub 2021 Nov 12. J Magn Reson Imaging. 2022. PMID: 34767682 Free PMC article.
References
-
- Stabile A, Giganti F, Rosenkrantz AB, et al. Multiparametric MRI for prostate cancer diagnosis: Current status and future directions. Nat Rev Urol 2020;17(1):41-61.
-
- Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 2019;76(3):340-351.
-
- Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol 2016;69(1):16-40.
-
- Brancato V, Cavaliere C, Salvatore M, Monti S. Non-Gaussian models of diffusion weighted imaging for detection and characterization of prostate cancer: A systematic review and meta-analysis. Sci Rep 2019;9(1):16837.
-
- Shukla-Dave A, Obuchowski NA, Chenevert TL, et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging 2019;49(7):e101-e121.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical